pediatric
FDA Approves Maralixibat for Cholestatic Pruritus in PFIC
The FDA approved Livmarli for cholestatic pruritus in patients 5+ years with PFIC.
MARCH 17, 2024
Exposure to Anti-Seizure Medications Does Not Appear to Harm Neurologic Development in Young Children
Young children who were exposed to commonly prescribed anti-seizure medications in utero do not have worse ...
SEPTEMBER 28, 2023
Award-Winning Tools for Optimizing Pediatric Vancomycin Rx
SAN FRANCISCO—In two separate award-winning studies presented at the 2022 ACCP Global Conference on Clinical ...
APRIL 20, 2023
Genetic Testing for Infants With Unexplained Epilepsy Can Inform Management
Genetic diagnoses for infants and very young children presenting with epilepsy can have a meaningful impact on ...
FEBRUARY 21, 2023
Bacterial Superinfections Rare in Kids With Viral Respiratory Infections
Although cases of bacterial superinfection are relatively rare, patients with superinfection are likely to have ...
FEBRUARY 18, 2021
Bacterial Superinfections Rare in Kids With Viral Respiratory Infections
Although cases of bacterial superinfection are relatively rare, patients with superinfection are likely to have ...
FEBRUARY 18, 2021
Quick Identification Necessary for Managing Pediatric Sepsis
Timely identification of pediatric sepsis and resuscitation result in improved outcomes, according to interim ...
FEBRUARY 9, 2021
Opioid Sparing Is Goal of Pediatric Pain Management
To address the undertreatment of both acute and chronic pain in children, more clinicians are turning to multimodal ...
AUGUST 15, 2019
Rare Pediatric Skin Conditions Often Get Expensive Inconsistent Care
Although children who develop SJS or TEN may experience high rates of complications, death and recurrence are rare. ...
JULY 10, 2018
FDA Moves to Reduce Use of Opioid Containing Cough Meds
FDA: Prescription opioid cough meds containing codeine or hydrocodone will no longer be indicated to treat cough in ...
JANUARY 17, 2018
FDA Evaluating Prescription Opioids in Pediatric Cough Medicines
The FDA has announced that it is “carefully evaluating” prescription cough suppressants for children, ...
SEPTEMBER 5, 2017
Opioids for Pain Management In Infants and Children: A High Standard For Prescribers
Although misguided prescribing patterns are partly to blame for the ongoing opioids epidemic, the problem begins ...
APRIL 7, 2017
